or Try an Advanced Search...

    Technical Analysis for AKYA - Akoya BioSciences, Inc.

    Grade Last Price % Change Price Change
    F 2.85 -1.72% -0.05
    AKYA closed down 1.72 percent on Friday, May 17, 2024, on 1.86 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical AKYA trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Volume Surge Other -1.72%
    Calm After Storm Range Contraction -1.72%
    Lower Bollinger Band Walk Weakness -1.72%
    New 52 Week Low Weakness -1.72%
    Outside Day Range Expansion -1.72%
    Older End-of-Day Signals for AKYA ...

       Recent Intraday Alerts

    Alert Time
    Up 1% 1 day ago
    Possible Inside Day 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    1.5x Volume Pace 1 day ago
    Down 3% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    AKYA Chart by TradingView
    Basic chart:

    Profile

    Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Disease Imaging

    Is AKYA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
    May 6 Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    May 6 Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
    Apr 5 Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
    Mar 5 Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript
    Mar 5 Q4 2023 Akoya Biosciences Inc Earnings Call
    Mar 5 Akoya Biosciences, Inc. (AKYA) Q4 2023 Earnings Call Transcript
    Mar 4 Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook
    Mar 4 Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates
    Mar 4 Recap: Akoya Biosciences Q4 Earnings
    See more AKYA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.8
    52 Week Low 2.65
    Average Volume 217,262
    200-Day Moving Average 4.63
    50-Day Moving Average 4.23
    20-Day Moving Average 3.77
    10-Day Moving Average 3.66
    Average True Range 0.32
    RSI (14) 27.54
    ADX 32.42
    +DI 12.03
    -DI 32.33
    Chandelier Exit (Long, 3 ATRs) 3.68
    Chandelier Exit (Short, 3 ATRs) 3.62
    Upper Bollinger Bands 4.74
    Lower Bollinger Band 2.80
    Percent B (%b) 0.03
    BandWidth 51.52
    MACD Line -0.31
    MACD Signal Line -0.20
    MACD Histogram -0.1146
    Fundamentals Value
    Market Cap 139.87 Million
    Num Shares 49.1 Million
    EPS -1.73
    Price-to-Earnings (P/E) Ratio -1.65
    Price-to-Sales 3.17
    Price-to-Book 4.70
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.15
    Resistance 3 (R3) 3.16 3.06 3.10
    Resistance 2 (R2) 3.06 2.99 3.06 3.08
    Resistance 1 (R1) 2.96 2.94 2.91 2.95 3.07
    Pivot Point 2.86 2.86 2.84 2.86 2.86
    Support 1 (S1) 2.76 2.79 2.71 2.75 2.63
    Support 2 (S2) 2.66 2.74 2.66 2.62
    Support 3 (S3) 2.56 2.66 2.60
    Support 4 (S4) 2.55